Christof Koch is taking on one of science’s deepest mysteries: whether the brain creates conscious experience at all. He frames the issue as the “hard problem,” and his core claim is blunt: materialism has yet to solve it.

That matters because this is not just a philosophical debate with a distant, academic audience. Koch’s argument is aimed at the gap between what brains do in biology terms and what it feels like to be a conscious being. If the brain is not the producer of consciousness, then “explanations” built around brain activity as the full story can fall apart. The work also points toward puzzling, high-stakes phenomena like near-death experiences and terminal lucidity, suggesting that what happens during extreme bodily disruption may not map cleanly onto brain-generated experience.

To understand why executives should care, you have to understand how this conversation will behave in the real world: it will move faster than the underlying science, because it touches investor narratives, clinical risk, and public trust. Near-death experiences and terminal lucidity sit at the intersection of medicine and meaning. When people hear that consciousness might persist or emerge in conditions where the brain is widely considered compromised, they do not just wonder. They ask for explanations, protocols, and assurances. Boards and leaders in health, biotech, and neurotech will increasingly face questions about what their products and research are really claiming, even when those claims are implicit.

There is also a second-order implication for how research programs get shaped. Koch’s stance is a challenge to materialism, the view that everything about mind can be reduced to material processes. When a respected researcher argues that materialism has not solved the “hard problem,” it pressures the field to confront what it has been treating as solved, or at least assumed. That can create incentive shifts. Teams may broaden hypotheses, rethink experimental designs, or widen the scope of what counts as relevant data. Even if the mainstream of neuroscience does not flip overnight, funding and attention can still pivot toward approaches that can accommodate experiences that do not track neatly with the usual models.

Regulatory framing is likely to be the quieter but more consequential battlefield. Health agencies tend to evaluate interventions based on safety, efficacy, and evidence quality. But consciousness research often comes with adjacent claims: about outcomes that are hard to measure and easy to overstate. Phenomena like near-death experiences and terminal lucidity can become part of public-facing narratives, even when clinical endpoints remain unclear. For decision-makers, that means governance needs to anticipate the storytelling risk. It is not enough to ask whether a therapy works in a clinical sense. Leaders also have to watch how it is described, what patient communications imply, and what claims might be interpreted as evidence that consciousness is independent of brain function.

Koch’s work, as described in this ScienceDaily piece, points toward the possibility that consciousness may be “woven into reality itself.” That is a strong direction, and it changes the stakes for how people interpret brain-based findings. If consciousness is woven into reality rather than created solely by the brain, then brain activity may be a channel, correlation, or filter rather than the whole generator of experience. That would not automatically make medical interventions meaningless. But it would change how researchers connect mechanisms to outcomes, and it would complicate the logic chain between observing neural signals and claiming to explain conscious experience.

For boards and senior leaders in neighboring domains, the strategic takeaway is simple but uncomfortable: controversies about consciousness are not waiting for a perfect scientific consensus. Koch’s framing emphasizes that the “hard problem” remains unsolved and that there are “puzzling phenomena” such as near-death experiences and terminal lucidity that resist easy reduction. In the near term, that likely translates into more uncertainty, more public debate, and more demand for careful, evidence-backed communication. The companies and institutions that handle that uncertainty well will be the ones that treat these questions as governance and risk issues, not just as curiosity. And if the field gradually moves toward a different view of consciousness, the winners will be the organizations ready to update their assumptions without losing credibility.